With the analysis among 72 patents, we discovered top 22 key players by total patent application. Allergan, Inc., Teva Pharmaceutical Industries Ltd., Hangzhou Neoantigen Therapeutics Co., Ltd. are dominant in this area. They take 40.28% of the total patent filing.
California, United States
Patent: 13
Teva Pharmaceutical Industries Ltd.
Hangzhou Neoantigen Therapeutics Co., Ltd.
Zhejiang Sheng, China
Patent: 7
Massachusetts, United States
Patent: 6
Yeda Research & Development Co. Ltd.
Noord-Holland, Netherlands
Patent: 5
Pennsylvania, United States
Patent: 4
New Jersey, United States
Patent: 3
Illinois, United States
Patent: 3
Amicus Therapeutics, Inc.
New Jersey, United States
Patent: 2
With the analysis among 1 patents, we discovered top 1 start-ups by total patent application.
Emerald Health Pharmaceuticals, Inc.
California, United States
Patent: 1
With the analysis among related 22 patents applied in the last 5 years. We discover 11 most active companies in this area. The fast-growing Hangzhou Neoantigen Therapeutics Co., Ltd., Shanghai Mingpin Medical Data Technology Co., Ltd, Tencent Technology (Shenzhen) Co., Ltd. take 45.45% of patent filing during this period.
Hangzhou Neoantigen Therapeutics Co., Ltd.
Zhejiang Sheng, China
Patent: 7
Shanghai Mingpin Medical Data Technology Co., Ltd
Shanghai Shi, China
Patent: 2
Tencent Technology (Shenzhen) Co., Ltd.
Guangdong Sheng, China
Patent: 1
Thrombosis Research Institute
Amicus Therapeutics, Inc.
New Jersey, United States
Patent: 1
Emerald Health Pharmaceuticals, Inc.
California, United States
Patent: 1
MUSC Foundation for Research Development
South Carolina, United States
Patent: 1
Fujian Sheng, China
Patent: 1
Texas, United States
Patent: 1
Shanghai Pulmonary Hospital
Shanghai Shi, China
Patent: 1
With the analysis among related 22 patents in last 5 years, we discover 10 new entrants. Hangzhou Neoantigen Therapeutics Co., Ltd., Shanghai Mingpin Medical Data Technology Co., Ltd, Tencent Technology (Shenzhen) Co., Ltd. are the most active new entrants in this area.
Hangzhou Neoantigen Therapeutics Co., Ltd.
Zhejiang Sheng, China
Patent: 7
Shanghai Mingpin Medical Data Technology Co., Ltd
Shanghai Shi, China
Patent: 2
Tencent Technology (Shenzhen) Co., Ltd.
Guangdong Sheng, China
Patent: 1
Thrombosis Research Institute
Emerald Health Pharmaceuticals, Inc.
California, United States
Patent: 1
MUSC Foundation for Research Development
South Carolina, United States
Patent: 1
Fujian Sheng, China
Patent: 1
Texas, United States
Patent: 1
Shanghai Pulmonary Hospital
Shanghai Shi, China
Patent: 1
Changchun Inst of Applied Chem Chinese Academy of Sciences
Jilin Sheng, China
Patent: 1
With the analysis among 14 patents, we discovered top 4 universities and scientific research institutions by total patent application. University of Technology Sydney, Xiamen University, Guangxi University are dominant in this area. They take 57.14% of the total patent filing.
University of Technology Sydney
New South Wales, Australia
Patent: 1
Fujian Sheng, China
Patent: 1
Guangxi Zhuangzu Zizhiqu, China
Patent: 1
Changchun Inst of Applied Chem Chinese Academy of Sciences
Jilin Sheng, China
Patent: 1